Effendy A W, Zamri-Saad M, Puspa R, Rosiah S
Faculty of Veterinary Medicine and Animal Science, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
Vet Rec. 1998 Apr 18;142(16):428-31. doi: 10.1136/vr.142.16.428.
A trial was conducted to compare the efficacy of intranasal vaccination in protecting goats against pneumonic pasteurellosis with intramuscular vaccination using an oil adjuvant vaccine, and a combination of the two methods. Forty goats were divided into four equal groups. Group 1 was vaccinated twice intranasally with formalin-killed Pasteurella haemolytica A2, group 2 was vaccinated twice intramuscularly with an oil adjuvant vaccine containing P haemolytica A7, and group 3 was initially vaccinated intranasally with the formalin-killed P haemolytica A2 followed by intramuscular vaccination with the oil adjuvant vaccine. In each group the two vaccinations were carried out four weeks apart. Group 4 was the unvaccinated control group. All goats were challenged intratracheally with 4 ml of an inoculum containing live P haemolytica A2 at a concentration of 1.3 x 10(7) colony forming units/ml two weeks after the last vaccination and were killed 14 days after the challenge. Although group 2 showed the highest clinical score following the challenge, deaths were observed only in group 3. Three goats in group 1 had pneumonic lung lesions, compared with six goats in group 2 and all the goats in groups 3 and 4. The lung lesions in group 1 were significantly (P < 0.05) less severe than in groups 3 and 4. Similarly, the lesions in group 2 were markedly less severe than in groups 3 and 4, although the differences were not significant. The difference between the extent of the lung lesions in the goats in groups 1 and 2 was not significant. Antibody against P haemolytica A2 in group 1 reached peak levels and was significantly (P < 0.01) higher than in the control group one week after the second vaccination, before declining.
进行了一项试验,以比较鼻内接种疫苗、使用油佐剂疫苗进行肌肉注射接种以及两种方法联合使用在保护山羊抵抗肺炎巴氏杆菌病方面的效果。40只山羊被分成四组,每组数量相等。第1组用福尔马林灭活的溶血巴氏杆菌A2进行两次鼻内接种;第2组用含有溶血巴氏杆菌A7的油佐剂疫苗进行两次肌肉注射接种;第3组先用福尔马林灭活的溶血巴氏杆菌A2进行鼻内接种,随后用该油佐剂疫苗进行肌肉注射接种。每组的两次接种均间隔四周进行。第4组为未接种疫苗的对照组。在最后一次接种两周后,所有山羊均经气管内接种4毫升浓度为1.3×10⁷菌落形成单位/毫升的含有活溶血巴氏杆菌A2的接种物,并在接种后14天处死。尽管在接种后第2组的临床评分最高,但仅在第3组观察到死亡情况。第1组有3只山羊出现肺炎性肺损伤,第2组有6只山羊出现,第3组和第4组所有山羊均出现。第1组的肺损伤明显(P<0.05)比第3组和第4组轻。同样,第2组的损伤明显比第3组和第4组轻,尽管差异不显著。第1组和第2组山羊肺损伤程度的差异不显著。第1组中针对溶血巴氏杆菌A2的抗体在第二次接种后一周达到峰值水平,且显著(P<0.01)高于对照组,随后下降。